Elanco/Bayer crosses finish line with FTC clearance

The Federal Trade Commission has conditionally approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, granting the final antitrust clearance the companies needed to close the deal.


Get unlimited access to all Global Competition Review content